CareDx, Inc
General ticker "CDNA" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $1.0B (TTM average)
CareDx, Inc follows the US Stock Market performance with the rate: 51.1%.
Estimated limits based on current volatility of 3.9%: low 62.09$, high 67.15$
Factors to consider:
- Total employees count: 765 (+17.7%) as of 2025
- US accounted for 74.4% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: History of losses, Medicare reimbursement, Third-party risks, Inability to raise capital, Labor/talent shortage/retention
- Current price 95.1% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [18.37$, 32.80$]
- 2026-12-31 to 2027-12-31 estimated range: [17.81$, 32.20$]
Financial Metrics affecting the CDNA estimates:
- Positive: with PPE of -98.3 at the end of fiscal year the price was neutral
- Positive: 2.37 < Operating cash flow per share per price, % of 4.05
- Negative: negative Industry operating cash flow (median)
- Negative: 1.34 < Inventory ratio change, % of 1.36
- Positive: -13.52 < Operating profit margin, % of -7.60
- Negative: 0.12 < Industry inventory ratio change (median), % of 0.16
- Negative: Investing cash flow per share per price, % of 0.21 <= 2.08
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Net income
- Positive: 69.38 < Shareholder equity ratio, % of 73.35 <= 81.92
Short-term CDNA quotes
Long-term CDNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $184.02MM | $333.79MM | $374.10MM |
| Operating Expenses | $387.39MM | $293.02MM | $404.88MM |
| Operating Income | $-203.36MM | $40.77MM | $-30.78MM |
| Non-Operating Income | $13.22MM | $12.09MM | $9.70MM |
| R&D Expense | $82.42MM | $72.41MM | $71.43MM |
| Income(Loss) | $-190.14MM | $52.86MM | $-21.08MM |
| Taxes | $0.14MM | $0.31MM | $0.27MM |
| Net Income(Loss)* | $-190.28MM | $52.55MM | $-21.35MM |
| Stockholders Equity | $261.33MM | $378.43MM | $303.10MM |
| Inventory | $19.47MM | $19.50MM | $26.70MM |
| Assets | $466.83MM | $491.05MM | $413.23MM |
| Operating Cash Flow | $-18.39MM | $38.05MM | $42.03MM |
| Capital expenditure | $9.24MM | $6.48MM | $5.91MM |
| Investing Cash Flow | $40.45MM | $-0.48MM | $2.16MM |
| Financing Cash Flow | $-29.61MM | $-5.61MM | $-93.39MM |
| Earnings Per Share** | $-3.54 | $1.00 | $-0.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.